Latest Commercialization News

High Peak Royalties finalises the sale of its geothermal subsidiary Torrens Energy to Northstar Energy, gaining significant equity and royalty interests while advancing South Australia's clean energy ambitions.

Comms Group Limited has finalized a new three-year debt refinancing agreement with Westpac, improving its financial flexibility and positioning for future acquisitions.

Proteomics International Laboratories has achieved the prestigious CAP accreditation for its US lab and installed a new mass spectrometry platform, setting the stage for the 2026 launch of its Promarker diagnostic tests in America.

Clarity Pharmaceuticals’ novel diagnostic agent Cu-SAR-bisPSMA has been selected for oral presentation at the prestigious European Association of Urology Congress 2026, following promising Phase II trial results demonstrating superior detection of prostate cancer recurrence.

Audio Pixels has successfully developed an independent MEMS fabrication process for its second-generation digital loudspeaker, overcoming previous manufacturing hurdles and paving the way for scalable production.

Enlitic has locked in commitments for an A$8 million convertible note capital raise, with initial funds arriving immediately and the remainder pending shareholder approval. This funding aims to extend the company’s runway as it advances its AI-driven healthcare solutions.

The Lederer Group, holding 42.7% of Elanor Commercial Property Fund securities, is pushing to replace the fund’s responsible entity and manager, aiming to reduce management fees and reshape governance.

Racura Oncology has appointed Beyond Drug Development to oversee its HARNESS-1 Phase 1a/b trial combining RC220 with osimertinib in EGFR-mutated non-small cell lung cancer patients, marking a key step toward clinical advancement.

Elanor Investors Group has agreed to step down as manager of the Elanor Commercial Property Fund, accepting $8.5 million in compensation as Lederer Group moves to assume control. The transition promises fee savings and closer alignment with investors.

EPX Limited has successfully completed a $2.14 million private placement to institutional investors, positioning itself to acquire Wattwatchers Pty Limited and invest in new technology initiatives. An upcoming Share Purchase Plan will offer existing shareholders further participation opportunities.

Adherium Limited has exceeded its 2025 shipment goals by delivering over 4,600 Hailie® Smartinhaler® devices, including more than 2,000 to Remote Patient Monitoring patients, signaling robust operational momentum.

Powerhouse Ventures has entered a strategic partnership with GlobalDots to back its new Burleigh Ventures Critical Infrastructure Opportunities Fund, aiming to capitalize on emerging technologies in AI, quantum, and cloud infrastructure.